Comments
Loading...

Legend Biotech

LEGNNASDAQ
$55.30
-0.6-1.07%
Last update: 11:27 AM
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$94.00
Lowest Price Target1
$60.00
Consensus Price Target1
$80.87

want to know what
the Bulls & Bears Say?

Legend Biotech (NASDAQ:LEGN) Stock, Analyst Ratings, Price Targets, Forecasts

Legend Biotech Corp has a consensus price target of $80.87 based on the ratings of 20 analysts. The high is $94 issued by Barclays on January 24, 2024. The low is $60 issued by Deutsche Bank on May 23, 2024. The 3 most-recent analyst ratings were released by TD Cowen, BMO Capital, and HC Wainwright & Co. on July 15, 2024, July 3, 2024, and July 3, 2024, respectively. With an average price target of $76.67 between TD Cowen, BMO Capital, and HC Wainwright & Co., there's an implied 38.64% upside for Legend Biotech Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
1
May
2
Jun
1
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

TD Cowen
BMO Capital
HC Wainwright & Co.
RBC Capital
Piper Sandler

1calculated from analyst ratings

Analyst Ratings for Legend Biotech

Buy NowGet Alert
07/15/2024Buy Now21.16%TD Cowen
Yaron Werber
$71 → $67MaintainsBuyGet Alert
07/03/2024Buy Now62.75%BMO Capital
Kostas Biliouris
$90 → $90MaintainsOutperformGet Alert
07/03/2024Buy Now32.01%HC Wainwright & Co.
Mitchell Kapoor
$73 → $73ReiteratesBuy → BuyGet Alert
06/21/2024Buy Now55.52%RBC Capital
Leonid Timashev
$86 → $86ReiteratesOutperform → OutperformGet Alert
06/17/2024Buy Now62.75%Piper Sandler
Edward Tenthoff
$90 → $90ReiteratesOverweight → OverweightGet Alert
06/17/2024Buy Now59.13%Truist Securities
Asthika Goonewardene
→ $88Initiates → BuyGet Alert
06/06/2024Buy Now32.01%HC Wainwright & Co.
Mitchell Kapoor
$73 → $73ReiteratesBuy → BuyGet Alert
06/04/2024Buy Now32.01%HC Wainwright & Co.
Mitchell Kapoor
$73 → $73ReiteratesBuy → BuyGet Alert
05/24/2024Buy Now32.01%HC Wainwright & Co.
Mitchell Kapoor
$86 → $73MaintainsBuyGet Alert
05/23/2024Buy Now8.5%Deutsche Bank
James Shin
→ $60Initiates → BuyGet Alert
05/14/2024Buy Now55.52%RBC Capital
Leonid Timashev
$85 → $86MaintainsOutperformGet Alert
05/14/2024Buy Now55.52%HC Wainwright & Co.
Mitchell Kapoor
$87 → $86MaintainsBuyGet Alert
05/09/2024Buy Now57.32%HC Wainwright & Co.
Mitchell Kapoor
→ $87ReiteratesBuy → BuyGet Alert
04/23/2024Buy Now57.32%HC Wainwright & Co.
Mitchell Kapoor
→ $87ReiteratesBuy → BuyGet Alert
04/17/2024Buy Now17.54%Scotiabank
George Farmer
$65 → $65UpgradeSector Perform → Sector OutperformGet Alert
04/16/2024Buy Now57.32%HC Wainwright & Co.
Mitchell Kapoor
→ $87ReiteratesBuy → BuyGet Alert
04/03/2024Buy Now48.28%Cantor Fitzgerald
Rick Bienkowski
→ $82Initiates → OverweightGet Alert
04/01/2024Buy Now57.32%HC Wainwright & Co.
Mitchell Kapoor
→ $87ReiteratesBuy → BuyGet Alert
03/18/2024Buy Now57.32%HC Wainwright & Co.
Mitchell Kapoor
→ $87ReiteratesBuy → BuyGet Alert
03/18/2024Buy Now46.47%UBS
Ashwani Verma
$76 → $81MaintainsBuyGet Alert
03/13/2024Buy Now57.32%HC Wainwright & Co.
Mitchell Kapoor
→ $87ReiteratesBuy → BuyGet Alert
03/13/2024Buy Now55.52%Raymond James
Sean McCutcheon
→ $86Initiates → OutperformGet Alert
03/12/2024Buy Now53.71%RBC Capital
Leonid Timashev
→ $85ReiteratesOutperform → OutperformGet Alert
03/08/2024Buy Now53.71%RBC Capital
Leonid Timashev
→ $85ReiteratesOutperform → OutperformGet Alert
03/07/2024Buy Now53.71%RBC Capital
Leonid Timashev
→ $85ReiteratesOutperform → OutperformGet Alert
01/24/2024Buy Now69.98%Barclays
Gena Wang
$93 → $94MaintainsOverweightGet Alert
12/22/2023Buy Now57.32%HC Wainwright & Co.
Mitchell Kapoor
→ $87ReiteratesBuy → BuyGet Alert
12/19/2023Buy Now17.54%Scotiabank
George Farmer
→ $65Initiates → Sector PerformGet Alert
11/15/2023Buy Now57.32%HC Wainwright & Co.
Mitchell Kapoor
$86 → $87MaintainsBuyGet Alert
10/18/2023Buy Now68.17%Barclays
Gena Wang
$92 → $93MaintainsOverweightGet Alert
10/18/2023Buy Now55.52%HC Wainwright & Co.
Mitchell Kapoor
$85 → $86MaintainsBuyGet Alert
08/16/2023Buy Now53.71%HC Wainwright & Co.
Mitchell Kapoor
→ $85ReiteratesBuy → BuyGet Alert
07/21/2023Buy Now53.71%HC Wainwright & Co.
Mitchell Kapoor
$82 → $85MaintainsBuyGet Alert
07/21/2023Buy Now66.37%Barclays
Gena Wang
$90 → $92MaintainsOverweightGet Alert
07/20/2023Buy Now53.71%Morgan Stanley
Matthew Harrison
$65 → $85MaintainsOverweightGet Alert
06/16/2023Buy Now50.09%RBC Capital
Leonid Timashev
→ $83ReiteratesOutperform → OutperformGet Alert
06/13/2023Buy Now62.75%BTIG
Justin Zelin
$85 → $90MaintainsBuyGet Alert
06/08/2023Buy Now48.28%HC Wainwright & Co.
Mitchell Kapoor
→ $82ReiteratesBuy → BuyGet Alert
06/06/2023Buy Now48.28%HC Wainwright & Co.
Mitchell Kapoor
$77 → $82MaintainsBuyGet Alert
05/25/2023Buy NowWilliam Blair
Sami Corwin
Initiates → Market PerformGet Alert
05/22/2023Buy NowDaiwa Capital
Wilfred Yuen
Initiates → BuyGet Alert
05/22/2023Buy Now39.24%HC Wainwright & Co.
Mitchell Kapoor
→ $77ReiteratesBuy → BuyGet Alert
05/19/2023Buy Now50.09%RBC Capital
Leonid Timashev
$74 → $83MaintainsOutperformGet Alert
05/19/2023Buy Now62.75%Barclays
Gena Wang
$65 → $90MaintainsOverweightGet Alert
04/25/2023Buy Now62.75%BMO Capital
Kostas Biliouris
$79 → $90MaintainsOutperformGet Alert
04/20/2023Buy Now39.24%HC Wainwright & Co.
Mitchell Kapoor
$66 → $77MaintainsBuyGet Alert
04/20/2023Buy Now53.71%BTIG
Justin Zelin
$75 → $85MaintainsBuyGet Alert
04/19/2023Buy Now37.43%JP Morgan
Jessica Fye
$65 → $76MaintainsOverweightGet Alert
04/18/2023Buy Now19.35%HC Wainwright & Co.
Mitchell Kapoor
→ $66Reiterates → BuyGet Alert
04/12/2023Buy Now19.35%HC Wainwright & Co.
Mitchell Kapoor
→ $66Reiterates → BuyGet Alert
04/03/2023Buy Now19.35%HC Wainwright & Co.
Mitchell Kapoor
→ $66Reiterates → BuyGet Alert
03/29/2023Buy Now19.35%HC Wainwright & Co.
Mitchell Kapoor
→ $66Initiates → BuyGet Alert
03/24/2023Buy Now32.01%RBC Capital
Leonid Timashev
→ $73Initiates → OutperformGet Alert
01/25/2023Buy Now17.54%Barclays
Gena Wang
$53 → $65MaintainsOverweightGet Alert
01/24/2023Buy Now17.54%Morgan Stanley
Matthew Harrison
$60 → $65MaintainsOverweightGet Alert
12/20/2022Buy Now41.05%Piper Sandler
Edward Tenthoff
$72 → $78MaintainsOverweightGet Alert
12/06/2022Buy Now17.54%JP Morgan
Jessica Fye
$61 → $65MaintainsOverweightGet Alert
12/06/2022Buy Now19.35%UBS
Ashwani Verma
→ $66Initiates → BuyGet Alert
11/02/2022Buy NowEvercore ISI Group
Umer Raffat
Initiates → OutperformGet Alert
11/01/2022Buy NowCowen & Co.
Yaron Werber
Initiates → OutperformGet Alert
10/31/2022Buy NowGuggenheim
Kelsey Goodwin
Initiates → NeutralGet Alert
10/13/2022Buy Now8.5%Morgan Stanley
Matthew Harrison
$63 → $60MaintainsOverweightGet Alert
07/15/2022Buy Now13.92%Morgan Stanley
Matthew Harrison
$55 → $63MaintainsOverweightGet Alert
06/17/2022Buy Now39.24%BMO Capital
Kostas Biliouris
→ $77Initiates → OutperformGet Alert
03/15/2022Buy Now-4.16%Barclays
Gena Wang
→ $53Initiates → OverweightGet Alert
03/07/2022Buy Now-0.54%Morgan Stanley
Matthew Harrison
$51 → $55MaintainsOverweightGet Alert
01/31/2022Buy Now-7.78%Morgan Stanley
Matthew Harrison
→ $51UpgradeEqual-Weight → OverweightGet Alert
01/06/2022Buy NowMorgan Stanley
Matthew Harrison
DowngradeOverweight → Equal-WeightGet Alert
12/21/2021Buy Now19.35%Piper Sandler
Edward Tenthoff
→ $66Initiates → OverweightGet Alert
10/12/2021Buy Now-7.78%Morgan Stanley
Matthew Harrison
MaintainsOverweightGet Alert

FAQ

Q

What is the target price for Legend Biotech (LEGN) stock?

A

The latest price target for Legend Biotech (NASDAQ:LEGN) was reported by TD Cowen on July 15, 2024. The analyst firm set a price target for $67.00 expecting LEGN to rise to within 12 months (a possible 21.16% upside). 35 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Legend Biotech (LEGN)?

A

The latest analyst rating for Legend Biotech (NASDAQ:LEGN) was provided by TD Cowen, and Legend Biotech maintained their buy rating.

Q

When was the last upgrade for Legend Biotech (LEGN)?

A

The last upgrade for Legend Biotech Corp happened on April 17, 2024 when Scotiabank raised their price target to $65. Scotiabank previously had a sector perform for Legend Biotech Corp.

Q

When was the last downgrade for Legend Biotech (LEGN)?

A

The last downgrade for Legend Biotech Corp happened on January 6, 2022 when Morgan Stanley changed their price target from N/A to N/A for Legend Biotech Corp.

Q

When is the next analyst rating going to be posted or updated for Legend Biotech (LEGN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Legend Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Legend Biotech was filed on July 15, 2024 so you should expect the next rating to be made available sometime around July 15, 2025.

Q

Is the Analyst Rating Legend Biotech (LEGN) correct?

A

While ratings are subjective and will change, the latest Legend Biotech (LEGN) rating was a maintained with a price target of $71.00 to $67.00. The current price Legend Biotech (LEGN) is trading at is $55.30, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch